Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Not yet recruiting
Safety and Systemic Exposure of YCANTH (VP-102) in Subjects With Common Warts (Verruca Vulgaris) (COVE-5)
NCT07881952· Phase 2· Verrica Pharmaceuticals Inc.· Source
Contact: Project Manager
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error